CN104474401A - Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof - Google Patents
Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof Download PDFInfo
- Publication number
- CN104474401A CN104474401A CN201410721985.7A CN201410721985A CN104474401A CN 104474401 A CN104474401 A CN 104474401A CN 201410721985 A CN201410721985 A CN 201410721985A CN 104474401 A CN104474401 A CN 104474401A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- hepatitis
- medicine composition
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating hepatitis B. The composition is characterized by being prepared from the following traditional Chinese medicinal raw materials in parts by weight: 15-25 parts of emblic leafflower fruits, 10-20 parts of underleaf pearls, 5-15 parts of liquorice, 5-15 parts of radix sophorae flavescentis, 5-10 parts of sophora alopecuroide, 5-10 parts of subprostrate sophora, 5-10 parts of phyllanthus niruri linn, 5-15 parts of polygonum cuspidatum, 5-15 parts of swertiam mussotii and 3-10 parts of rhizoma smilacis glabrae. The traditional Chinese medicine composition provided by the invention is a pure traditional Chinese medicine preparation which is free of toxic and side effects, low in cost and obvious in effect and has the comprehensive effects of being strong in anti-hepatitis b virus capacity, enhancing the immune function, strengthening the spleen and stomach, activating blood circulation to dissipate stasis, nourishing the spleen and stomach and treating jaundice and declining enzyme.
Description
Technical field
The present invention relates to Chinese medicine field, be specifically related to a kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof.
Background technology
Hepatitis B pathogenesis is complicated, and symptom is obstinate, and delay is difficult, thus very big to the health hazard of the mankind.Traditional medicine thinks that hepatitis B belongs to stagnation of liver-QI, hypochondriac pain, jaundice, pestilence, gathers category, and its cause of disease is got rid of evils in outward because positive QI-insufficiency is unable, causes the dark volt of epidemic disease poison and makes protracted inflammation not heal.Its pathogenesis is that the heresy of epidemic disease caused by damp-heat pathogen poison holds back volt taste, middle burnt stasis, production of fire due to stagnation of damp, cloudy liquid in consumer, and causes the hepatic and renal YIN deficiency; Its pathologic basis is the dirty imbalance of YIN and YANG of liver,spleen,kidney three, and pathogen stops up knot, damp and hot tired resistance qi depression to blood stasis.Traditional medicine for hepatitis B Therapeutic Principle mainly with removing toxic substances regulating qi to disperse stagnation be main, determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs is carried out in conjunction with Disease evolution, and combine raising body's immunity suppression virus, improve liver blood circulation, anti-hepatic fibrosis, promote that hepatocyte is repaired, its Therapeutic Method is with nourishing the liver, easing the affected liver, soothing liver-QI, regulating the flow of QI to dissipate blood stasis righting, clearing away heat-damp and promoting diuresis detoxifies.Doctor trained in Western medicine adopts antiviral, immunomodulating at present to the treatment of primary disease, protects the liver, falls the comprehensive drug treatment such as enzyme, antiinflammatory and fibrosis, but western modern medicine treatment also exists costly, the problems such as untoward reaction is many, and therapeutic effect is undesirable; Chinese medicine has outstanding advantage in treatment hepatitis B, but the Chinese medicine effectively treating hepatitis B is fewer, more and more can not meet the clinical demand for the treatment of hepatitis B.
Summary of the invention
For solving the problems of the technologies described above, the invention provides Chinese medicine composition of that a kind of pure Chinese medicine is made, that therapeutic effect is good, toxic and side effects is little treatment hepatitis B and preparation method thereof.
Concrete technical scheme of the present invention is as follows:
The Chinese medicine composition for the treatment of hepatitis B provided by the invention, it is characterized in that, be made up of the raw material of Chinese medicine of following parts by weight: Fructus Phyllanthi 15-25 part, Cacumen Securinegae Suffruticosae 10-20 part, Radix Glycyrrhizae 5-15 part, Radix Sophorae Flavescentis 5-15 part, Herba Sophorae alopecuroidis 5-10 part, Radix Sophorae Tonkinensis 5-10 part, Herba Scopariae 5-10 part, Rhizoma Polygoni Cuspidati 5-15 part, ZANGYINCHEN 5-15 part, Rhizoma Smilacis Glabrae 3-10 part.
The Chinese medicine composition of preferred treatment hepatitis B, is made up of the raw material of Chinese medicine of following parts by weight: Fructus Phyllanthi 20 parts, Cacumen Securinegae Suffruticosae 15 parts, 12 parts, Radix Glycyrrhizae, Radix Sophorae Flavescentis 10 parts, Herba Sophorae alopecuroidis 8 parts, Radix Sophorae Tonkinensis 8 parts, Herba Scopariae 6 parts, Rhizoma Polygoni Cuspidati 6 parts, ZANGYINCHEN 10 parts, Rhizoma Smilacis Glabrae 8 parts.
The preparation method of the Chinese medicine composition for the treatment of hepatitis B provided by the invention is weighed by weight by described each dry raw material of Chinese medicine, and mix homogeneously pulverizes 40-80 order, obtains powder.
Based on powder after co-grinding, be processed into dosage form described on tablet, pill, capsule preparations or other pharmaceuticss.
Based on powder after co-grinding, add suitable amount of adhesive as starch slurry, syrup etc., be pressed into pill, or incapsulate and make capsule medicament.
Equal every day taken three times by above-mentioned each preparation, and be grown up each dose 1-2 gram, and child is cut down according to the circumstance to 0.5-1 gram, bfore meals, warm water delivery service.Take phase diet acidic food.
The present invention has the following advantages: (1) has the comprehensive function that anti-hepatitis B virus ability is strong, enzyme falls in enhancing immunologic function, strengthening the spleen and stomach, activating blood circulation to dissipate blood stasis, tonifying the spleen and stomach, jaundice eliminating subcutaneous ulcer.(2) pharmaceutical composition provided by the invention is pure Chinese medicinal preparation, has no side effect, and with low cost, evident in efficacy.
Detailed description of the invention
The invention will be further described by the following examples.
Embodiment 1:
Get Fructus Phyllanthi 20 grams, Cacumen Securinegae Suffruticosae 15 grams, 12 grams, Radix Glycyrrhizae, Radix Sophorae Flavescentis 10 grams, Herba Sophorae alopecuroidis 8 grams, Radix Sophorae Tonkinensis 8 grams, Herba Scopariae 6 grams, Rhizoma Polygoni Cuspidati 6 grams, ZANGYINCHEN 10 grams, Rhizoma Smilacis Glabrae 8 grams, above-mentioned traditional Chinese medicinal material raw materials mix homogeneously is quantitatively taken after being crushed to 60 orders.
Embodiment 2:
Get Fructus Phyllanthi 15 grams, Cacumen Securinegae Suffruticosae 10 grams, 5 grams, Radix Glycyrrhizae, Radix Sophorae Flavescentis 5 grams, Herba Sophorae alopecuroidis 5 grams, Radix Sophorae Tonkinensis 5 grams, Herba Scopariae 5 grams, Rhizoma Polygoni Cuspidati 5 grams, ZANGYINCHEN 5 grams, Rhizoma Smilacis Glabrae 3 grams, above-mentioned traditional Chinese medicinal material raw materials mix homogeneously is quantitatively taken after being crushed to 40 orders.
Embodiment 3:
Get Fructus Phyllanthi 25 grams, Cacumen Securinegae Suffruticosae 20 grams, 15 grams, Radix Glycyrrhizae, Radix Sophorae Flavescentis 15 grams, Herba Sophorae alopecuroidis 10 grams, Radix Sophorae Tonkinensis 10 grams, Herba Scopariae 10 grams, Rhizoma Polygoni Cuspidati 15 grams, ZANGYINCHEN 15 grams, Rhizoma Smilacis Glabrae 10 grams, above-mentioned traditional Chinese medicinal material raw materials mix homogeneously is quantitatively taken after being crushed to 80 orders.
Above-described embodiment is only for example of the present invention is clearly described, and is not the restriction to embodiments of the present invention.For those of ordinary skill in the field, can also make other changes in different forms on the basis of the above description.Here exhaustive without the need to also giving all embodiments.And these belong to spirit institute's apparent change of extending out of the present invention or change and are still among protection scope of the present invention.
Claims (6)
1. treat the Chinese medicine composition of hepatitis B for one kind, it is characterized in that, be made up of the raw material of Chinese medicine of following parts by weight: Fructus Phyllanthi 15-25 part, Cacumen Securinegae Suffruticosae 10-20 part, Radix Glycyrrhizae 5-15 part, Radix Sophorae Flavescentis 5-15 part, Herba Sophorae alopecuroidis 5-10 part, Radix Sophorae Tonkinensis 5-10 part, Herba Scopariae 5-10 part, Rhizoma Polygoni Cuspidati 5-15 part, ZANGYINCHEN 5-15 part, Rhizoma Smilacis Glabrae 3-10 part.
2. the Chinese medicine composition for the treatment of hepatitis B according to claim 1, it is characterized in that, be made up of the raw material of Chinese medicine of following parts by weight: Fructus Phyllanthi 20 parts, Cacumen Securinegae Suffruticosae 15 parts, 12 parts, Radix Glycyrrhizae, Radix Sophorae Flavescentis 10 parts, Herba Sophorae alopecuroidis 8 parts, Radix Sophorae Tonkinensis 8 parts, Herba Scopariae 6 parts, Rhizoma Polygoni Cuspidati 6 parts, ZANGYINCHEN 10 parts, Rhizoma Smilacis Glabrae 8 parts.
3. the preparation method of the Chinese medicine composition for the treatment of hepatitis B according to claim 1 and 2, is characterized in that, concrete preparation method is: weighed by weight by described each dry raw material of Chinese medicine, and mix homogeneously pulverizes 40-80 order, obtains powder.
4. the preparation method of the Chinese medicine composition for the treatment of hepatitis B according to claim 3, is characterized in that: based on the powder that described mix homogeneously is pulverized, be processed into tablet, pill or capsule preparations.
5. the preparation method of the Chinese medicine composition for the treatment of hepatitis B according to claim 3, is characterized in that: based on the powder after mix homogeneously is pulverized, add suitable amount of adhesive, be pressed into pill or incapsulate and make capsule medicament.
6. the preparation method of the Chinese medicine composition for the treatment of hepatitis B according to claim 5, is characterized in that described binding agent is starch slurry or syrup.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410721985.7A CN104474401A (en) | 2014-12-03 | 2014-12-03 | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410721985.7A CN104474401A (en) | 2014-12-03 | 2014-12-03 | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104474401A true CN104474401A (en) | 2015-04-01 |
Family
ID=52749102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410721985.7A Pending CN104474401A (en) | 2014-12-03 | 2014-12-03 | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104474401A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104888017A (en) * | 2015-06-18 | 2015-09-09 | 王萧 | Medicine for treating hepatitis B |
| CN106924340A (en) * | 2015-12-30 | 2017-07-07 | 姚萍 | Application of the Swertia mussotii in the medicine for preparing treatment virus B hepatitis |
| CN109554421A (en) * | 2018-12-10 | 2019-04-02 | 王召利 | A kind of plant active peptides for hepatitis B rehabilitation and preparation method thereof, purposes |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
| CN1375325A (en) * | 2002-03-27 | 2002-10-23 | 李少华 | Composite medicine for treating hepatitis B |
| CN101618156A (en) * | 2009-04-28 | 2010-01-06 | 辽宁本溪三药有限公司 | Medicine composition for treating hepatitis B and preparation method thereof |
-
2014
- 2014-12-03 CN CN201410721985.7A patent/CN104474401A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
| CN1375325A (en) * | 2002-03-27 | 2002-10-23 | 李少华 | Composite medicine for treating hepatitis B |
| CN101618156A (en) * | 2009-04-28 | 2010-01-06 | 辽宁本溪三药有限公司 | Medicine composition for treating hepatitis B and preparation method thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104888017A (en) * | 2015-06-18 | 2015-09-09 | 王萧 | Medicine for treating hepatitis B |
| CN106924340A (en) * | 2015-12-30 | 2017-07-07 | 姚萍 | Application of the Swertia mussotii in the medicine for preparing treatment virus B hepatitis |
| CN109554421A (en) * | 2018-12-10 | 2019-04-02 | 王召利 | A kind of plant active peptides for hepatitis B rehabilitation and preparation method thereof, purposes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014007760A1 (en) | Seven-star tea without excipient and method of preparing the same | |
| CN104083727A (en) | Traditional Chinese medicine composition for nourishing and protecting liver | |
| CN102423442B (en) | Double-component medicine for treating fatty liver and preparation method thereof | |
| CN104474401A (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
| CN102198226A (en) | Chinese herbal medicine composition for treating cancer | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN103705578B (en) | There is blood fat reducing and Chinese medicine preparation suppressing blood glucose rising effect and preparation method thereof | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| WO2018006641A1 (en) | Traditional chinese medicine for treating pregnant women suffering from spleen deficiency with damp harassment | |
| CN100488495C (en) | A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same | |
| CN101745043A (en) | Traditional Chinese medicine composite used for curing pregnant jaundice of newborn infant | |
| CN102335255A (en) | Chinese medicine for treating hyperlipidemia and fatty liver and preparation method thereof | |
| CN104771657A (en) | Traditional Chinese medicine composition for treating gastric ulcer | |
| CN102309648A (en) | Traditional Chinese medicine prescription for treating postpartum retention of lochia | |
| CN104116815A (en) | Stasis and stagnation eliminating decoction for treating primary hepatic carcinoma and preparation method thereof | |
| CN103720995A (en) | Pilled stomach protecting granule and powder | |
| CN103212032A (en) | Traditional Chinese medicine composition for treating gastric diseases | |
| CN104510944A (en) | Qi and yin deficiency syndrome nephrotic syndrome treatment drug | |
| CN102895507A (en) | Chinese medicine for treating leukoplakia vulvae and preparation method thereof | |
| CN102406913A (en) | Chinese medicinal composition for treating melancholia | |
| CN101732568B (en) | Chinese medicinal oral liquid for treating cancer and preparation method thereof | |
| CN102038906A (en) | Medicament for treating psoriasis | |
| CN101897904A (en) | Chinese medicine preparation for treating hepatitis | |
| CN101804118A (en) | Traditional Chinese medicine powder for preventing and treating talus necrosis | |
| CN105521150A (en) | Preparation method traditional Chinese medicine for reducing blood fat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150401 |